Matthew Campbell

Affiliations: 
Trinity College Dublin (University of Dublin) (Ireland) 
Google:
"Matthew Campbell"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Dion-Albert L, Dudek KA, Russo SJ, et al. (2023) Neurovascular adaptations modulating cognition, mood, and stress responses. Trends in Neurosciences. 46: 276-292
Dion-Albert L, Cadoret A, Doney E, et al. (2022) Vascular and blood-brain barrier-related changes underlie stress responses and resilience in female mice and depression in human tissue. Nature Communications. 13: 164
Veksler R, Vazana U, Serlin Y, et al. (2020) Slow blood-to-brain transport underlies enduring barrier dysfunction in American football players. Brain : a Journal of Neurology
Hashimoto Y, Campbell M. (2020) Tight junction modulation at the blood-brain barrier: Current and future perspectives. Biochimica Et Biophysica Acta. Biomembranes. 1862: 183298
Hudson N, Cahill M, Campbell M. (2020) Inner blood-retina barrier involvement in dry age-related macular degeneration (AMD) pathology. Neural Regeneration Research. 15: 1656-1657
Mulfaul K, Ozaki E, Fernando N, et al. (2020) Toll-like Receptor 2 Facilitates Oxidative Damage-Induced Retinal Degeneration. Cell Reports. 30: 2209-2224.e5
Naylor A, Hopkins A, Hudson N, et al. (2019) Tight Junctions of the Outer Blood Retina Barrier. International Journal of Molecular Sciences. 21
Hudson N, Campbell M. (2019) Inner Blood-Retinal Barrier Regulation in Retinopathies. Advances in Experimental Medicine and Biology. 1185: 329-333
Hudson N, Celkova L, Hopkins A, et al. (2019) Dysregulated claudin-5 cycling in the inner retina causes retinal pigment epithelial cell atrophy. Jci Insight. 4
Campbell M, Doyle SL. (2019) Current perspectives on established and novel therapies for pathological neovascularization in retinal disease. Biochemical Pharmacology. 164: 321-325
See more...